Abstract:
Well-developed mouse models are important for understanding the pathogenesis and progression of immunological
response to viral infections in humans. Moreover, to test vaccines, anti-viral drugs and therapeutic agents, mouse models
are fundamental for preclinical investigations. Human viruses, however, seldom infect mice due to differences in the
cellular receptors used by the viruses for entry, as well as in the innate immune responses in mice and humans. In other
words, a species barrier exists when using mouse models for investigating human viral infections. Developing transgenic
(Tg) mice models expressing the human genes coding for viral entry receptors and knock-out (KO) mice models devoid
of components involved in the innate immune response have, to some extent, overcome this barrier. Humanized mouse
models are a third approach, developed by engrafting functional human cells and tissues into immunodeficient mice.
With an increase in the advancement of modern techniques used for genetic manipulation, humanized mice have become
an important asset. They are becoming indispensable for analyzing human viral diseases since they nearly recapitulate
the human disease. These mouse models also serve to test the efficacy of vaccines and antiviral agents. The development
of humanized mouse models offers a preclinical in vivo platform for further characterization of human viral infections
and human immune responses triggered by these virus particles. This review highlights recent progress in utilizing
humanized mice to decipher human specific immune responses against viral tropism.
